Skip to Main Content

2023 Board Meeting

September 18, 2023

The Maryland Prescription Drug Affordability Board invites you to attend the September Board Meeting, scheduled for Monday, September 18, 2023, at 2:00 pm. In the interest of public health and safety, the meeting will be held remotely. Part of the meeting may be conducted in closed session. Please register for the meeting here. After registering, you will receive a confirmation email with information about joining the webinar. PDAB staff politely requests that you mute your line after entering the meeting

PUBLIC COMMENT: The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email comments.pdab@maryland.gov no later than the close of business on Thursday, September 14, 2023, and provide (1) your name, (2) your address, and (3) the agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail

WRITTEN COMMENT: The public may also submit written comments on the Board’s pending decisions, or general comments regarding the Board’s work, to comments.pdab@maryland.gov. Please submit any written comments concerning this agenda no later than the close of business on Thursday, September 14, 2023.

AGENDA AND MEETING MATERIALS: The meeting agenda and meeting materials will be posted on the Board Meetings page when available.

September 13, 2023

The Maryland Prescription Drug Affordability Board invites you to attend an additional September Board Meeting, scheduled for Wednesday, September 13, 2023, at 9:00 am. In the interest of public health and safety, the meeting will be held remotely. Part of the meeting may be conducted in closed session. Please register for the meeting here. After registering, you will receive a confirmation email with information about joining the webinar. PDAB staff politely requests that you mute your line after entering the meeting

PUBLIC COMMENT: The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email comments.pdab@maryland.gov no later than the close of business on Friday, September 8, 2023, and provide (1) your name, (2) your address, and (3) the agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail

WRITTEN COMMENT: The public may also submit written comments on the Board’s pending decisions, or general comments regarding the Board’s work, to comments.pdab@maryland.gov. Please submit any written comments concerning this agenda no later than the close of business on Friday, September 8, 2023.

AGENDA AND MEETING MATERIALS: The meeting agenda and meeting materials will be posted on the Board Meetings page when available.

July 24, 2023

The Maryland Prescription Drug Affordability Board invites you to attend the July Board Meeting, scheduled for Monday, July 24, 2023, at 2:00 pm. In the interest of public health and safety, the meeting will be held remotely. Part of the meeting may be conducted in closed session. Please register for the meeting here. After registering, you will receive a confirmation email with information about joining the webinar. PDAB staff politely requests that you mute your line after entering the meeting

PUBLIC COMMENT: The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email comments.pdab@maryland.gov no later than the close of business on Friday, July 21, 2023, and provide (1) your name, (2) your address, and (3) the agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail

WRITTEN COMMENT: The public may also submit written comments on the Board’s pending decisions, or general comments regarding the Board’s work, to comments.pdab@maryland.gov. Please submit any written comments concerning this agenda no later than the close of business on Friday, July 21, 2023.

AGENDA AND MEETING MATERIALS: The meeting agenda and meeting materials will be posted on the Board Meetings page when available.

For previous drafts of the regulations and redlined versions, please visit the regulations page.

May 22, 2023

The Maryland Prescription Drug Affordability Board invites you to attend its upcoming Board Meeting, scheduled for Monday, May 22, 2023, at 2:00 pm. In the interest of public health and safety, the January Board Meeting will be held virtually. Please register for the meeting here. After registering, you will receive a confirmation email with information about joining the webinar. PDAB staff politely requests that you mute your line after entering the meeting

PUBLIC COMMENT: The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email comments.pdab@maryland.gov no later than the close of business on Friday, May 19, 2023, and provide (1) your name, (2) your address, and (3) the agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail

WRITTEN COMMENT: The public may also submit written comments on the Board’s pending decisions, or general comments regarding the Board’s work, to comments.pdab@maryland.gov. Please submit any written comments concerning this agenda no later than the close of business on May 19, 2023.

AGENDA AND MEETING MATERIALS: The meeting agenda and meeting materials will be posted on the Board Meetings page when available.

April 18, 2023

The Maryland Prescription Drug Affordability Board invites you to attend the rescheduled March Board Meeting, scheduled for Tuesday, April 18, 2023, at 2:00 pm. In the interest of public health and safety, the meeting will be held remotely. Part of the meeting may be conducted in closed session. Please register for the meeting here. In the interest of public health and safety, the meeting will be held remotely. After registering, you will receive a confirmation email with information about joining the webinar. PDAB staff politely requests that you mute your line after entering the meeting

PUBLIC COMMENT: The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email comments.pdab@maryland.gov no later than the close of business on April 14, 2023, and provide (1) your name, (2) your address, and (3) the agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail

WRITTEN COMMENT: The public may also submit written comments on the Board’s pending decisions, or general comments regarding the Board’s work, to comments.pdab@maryland.gov. Please submit any written comments concerning this agenda no later than the close of business on April 14, 2023.

AGENDA AND MEETING MATERIALS: The meeting agenda and meeting materials will be posted on the Board Meetings page when available.

DRAFT REGULATIONS: The Board is accepting written comments on the following draft regulations through May 2, 2023. Please submit all comments to comments.pdab@maryland.gov.

Draft Proposed Regulations for Comment

COMAR 14.01.01.01 – General Provisions (Definitions- NEW)

  • Written Comments due by May 2, 2023

COMAR 14.01.02.02 – Prescription Drug Affordability Fund (Fee Assessment, Exemption, Waiver, and Collection) Amendments

  • Written Comments due by May 2, 2023

COMAR 14.01.03.01-05 – (Cost Review Process)

  • Written Comments due by May 2, 2023

March 27, 2023

Please be advised that the March 27, 2023 Board meeting has been canceled and will be rescheduled.

January 23, 2023

The Maryland Prescription Drug Affordability Board invites you to attend its upcoming Board Meeting, scheduled for January 23, 2023, at 2:00 pm. In the interest of public health and safety, the January Board Meeting will be held virtually. Please register for the meeting here. After registering, you will receive a confirmation email with information about joining the webinar. PDAB staff politely requests that you mute your line after entering the meeting

PUBLIC COMMENT: The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email comments.pdab@maryland.gov no later than the close of business on January 20, 2023, and provide (1) your name, (2) your address, and (3) the agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail

WRITTEN COMMENT: The public may also submit written comments on the Board’s pending decisions, or general comments regarding the Board’s work, to comments.pdab@maryland.gov. Please submit any written comments concerning this agenda no later than the close of business on January 20, 2023.

AGENDA AND MEETING MATERIALS: The meeting agenda and meeting materials will be posted on the Board Meetings page when available.

2023 Board Meeting Schedule

The Prescription Drug Affordability Board regularly meets on the fourth Monday of every other month. The Board may add additional meetings or adjust its schedule as necessary. Any changes to the Board's schedule will be posted to this website and shared via our mailing list (which you can join here). Below is the regular meeting schedule for the Board for Calender Year 2023:

January 23, 2023 @ 2:00pm

March 27, 2023 @ 2:00pm  [CANCELED]

May 22, 2023 @ 2:00pm

July 24, 2023 @ 2:00pm

September 13, 2023 @ 9:00am

September 18, 2023 @ 2:00pm

November 27, 2023 @ 2:00pm